Close | |
![]() |
|
Figure 4: (a) Comparison of serum IDO levels between controls and subtypes of rosacea in female subjects. *Significantly different from control (P = 0.024). **Significantly different from control (P < 0.001). (b) Comparison of serum IDO levels between controls and period of rosacea in female subjects. ***Significantly different from control (P < 0.001). IDO: Indoleamine 2,3-dioxygenase |
|